ICU Medical (ICUI) Tops Q2 EPS by 24c

ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $1.88, $0.24 better than the analyst estimate of $1.64. Revenue for the quarter came in at $321.7 million versus the consensus estimate of $305.43 million.

Fiscal Year 2021 Guidance Update:

The Company is updating its full year 2021 guidance of adjusted EBITDA from a range of $245 million to $265 million to a range of $250 million to $260 million and adjusted diluted earnings per share from a range of $6.50 to $7.20 to a range of $6.80 to $7.20

(*Consensus sees FY EPS of $6.93)

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
• Citi on Texas Instruments: We are buyers into earnings